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Cells  with  many of the  features of mast  cells develop in cultures of normal 
mouse hematopoietic cells containing mast cell growth factor (1-8), an activity 
similar  or  identical  to  interleukin  3  (IL-3)  ~ (9-11),  histamine-producing  cell- 
stimulating  factor (9),  or P  cell-stimulating  factor (12-14).  Large numbers  of 
these cells (>10 s) can be generated as virtually homogeneous populations or as 
clones, thereby facilitating a  wide variety of biochemical and functional studies 
(reviewed in  15).  Yet,  despite  their  popularity as an  experimental  model,  the 
precise relationship  of these  cells to  mast  cell populations  observed  in  vivo is 
controversial. 
It has been clear from the beginning that the cultured cells differ in certain 
important  respects  from the  best-characterized cell type available  for detailed 
comparative  studies:  mature  peritoneal  mast  cells  (reviewed  in  15).  Cultured 
mast  cells appear  immature  by ultrastructure  (1,  2,  15),  contain  low  levels of 
histamine (1, 2, 5,  12,  15-18), and express fewer surface receptors for IgE than 
do mature peritoneal mast cells (2). In addition, cultured mast cells incorporate 
Na235804 into granule-associated chondroitin sulfates (2,  10,  17,  19), including 
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an oversulfated chondroitin that is designated chondroitin sulfate E (10, 19). By 
contrast, normal mouse peritoneal mast cells synthesize heparin (2,  19). 
However, peritoneal  mast cells are representative  of only one of two pheno- 
typically  distinct  mast  cell  populations  that  have  been  identified  in  murine 
rodents.  Maximow was probably the first to recognize that certain  mast cells in 
the  rat  intestinal  mucosa  were  atypical,  in  that  their  staining  characteristics 
differed from those of mast cells observed in other anatomical sites (20). Enerbfick 
greatly  extended  these  observations  and  defined  conditions  of fixation  and 
histochemical staining that discriminated between such atypical or mucosal mast 
cells  (MMC)  and  the  connective  tissue  type  mast  cells  (CTMC)  of the  skin, 
peritoneal cavity, and other sites (21). 
We (1,  2,  15)  and  several  other  investigators  (10,  14,  17)  have  noted  that 
cultured  murine  mast  cells  express  certain  characteristics  similar  to  those  of 
MMC.  MMC contain  low levels of histamine  (21,  22), and  microspectrophoto- 
metric evidence suggests that their granules contain a poorly sulfated glycosami- 
noglycan similar to chondroitin  sulfate (23). Cultured mast cells and MMC also 
exhibit similar patterns  of responsiveness to certain  secretagogues (I 7) and,  in 
the rat, contain a similar or identical granule-associated protease (24). 
Furthermore,  the  growth  of both  cultured  mast  cells  and  MMC  may  be 
regulated by similar signals.  Mucosal mast cells are exquisitely sensitive to T  cell 
regulation.  Striking  proliferation  of  MMC  occurs  during  T  cell-dependent 
responses to certain intestinal parasites in normal mice and rats (for reviews, see 
15, 21, 25-27).  By contrast,  athymic nude mice lack such a response (28). The 
nude  mouse  intestinal  mucosa  contains  MMC  precursors  (27),  however,  and 
MMC proliferation does occur if nude mice are reconstituted with T  cells before 
intestinal  infection (28). Cultured mast cells proliferate in response to mast cell 
growth factor (IL-3), which can be elaborated by cloned Ly-l+2  - inducer T  cells 
(i-4). In addition, Crapper et al. (29) reported that the survival of cultured mast 
cells injected into the skin of (B10pd X DBA/2)F1-Wf/Wf(BIOD2F1-Wf/W  f) mast 
cell-deficient mice required that the mice also contain a subcutaneous inoculum 
of the WEHI-3B tumor as a source of mast cell growth factor. 
Although  some authors have suggested that cultured mast cells may be com- 
mitted to express the MMC phenotype, we (1,  2,  15) and Yung and  Moore (8) 
entertained  an  alternative  hypothesis:  that  many of the properties of cultured 
mast cells might reflect their immaturity.  However, attempts to induce further 
maturation  of cultured  mast  cells in  vitro met  with  only limited  success.  The 
inducing agent sodium butyrate caused a marked inhibition of cultured mast cell 
proliferation, resulted in increased storage of histamine and chondroitin sulfate, 
and favored partial maturation of cytoplasmic granules (2, 30). But the cells did 
not  appear  fully mature  by ultrastructure  nor  did  they  synthesize  detectable 
amounts of heparin. 
In  the present  study,  we adopted a  different strategy:  we injected cultured 
mast cells directly into mast cell-deficient (WB X C57BL/6)FI-W/W  v (WBB6F1- 
W/W  v) mice and examined the cells' histochemical characteristics and ultrastruc- 
ture at different intervals up to 10 wk later. We performed similar experiments 
using  partially  purified  peritoneal  mast  cells  from  WBB6F~-+/+  mice.  When 
injected in vivo, cultured or peritoneal mast cells gave rise to mast cells in several NAKANO  ET  AL.  1027 
different anatomical  sites.  In the  peritoneal  cavity, skin,  spleen,  and  glandular 
stomach  muscularis  propria,  these  mast cells exhibited  features  of CTMC.  By 
contrast,  adoptively transferred mast cells identified  in the mucosa of the glan- 
dular stomach resembled MMC.  These results suggest that mast cell phenotype 
can be strikingly influenced by local microenvironmental factors. 
Materials and  Methods 
Mice.  The tissues of adult WBB6F1-W[W  v mice contain <1% the number of CTMC 
as do their normal (+/+) littermates (31,  32).  WBB6F1-W/W v mice also lack MMC (33). 
Both of these populations can be restored by transplantation of bone marrow cells derived 
from WBB6FI-+/+ mice (31-33). WBB6Fl-(W/W ~, +/+) and C57BL/6-bgJ/bg J mice were 
raised at the Osaka University Medical School or Shizuoka Laboratory Animal Center. 
Cells derived from C57BL/6-bgJ[bg J mice were used in some experiments because their 
giant granules represent a morphologic marker that can unequivocally identify the cells 
as of donor origin (34, 35). The original stocks of mutant mice were obtained from The 
Jackson Laboratory, Bar Harbor, ME, but W v and bg  J mutant genes have been maintained 
in C57BL/6 mice of our own inbred colony (more than 29 and 16 backcrosses, respectively, 
at the time of the present experiments) (36, 37). Mice were used at 2-6 mo of age. 
Cell Suspensions.  Mice were killed by decapitation. Bone marrow cells were recovered 
and suspended  in  Eagle's medium as described previously (38).  To harvest peritoneal 
cells,  2  ml of Eagle's medium  containing  10  IU/ml heparin  and  0.1%  bovine serum 
albumin (BSA) was injected into the peritoneal cavity, and the abdomen was massaged 
gently for  30  s.  The peritoneal  cavity was carefully opened,  and  the  fluid  containing 
peritoneal cells was aspirated with a pasteur pipette. When peritoneal cells were used for 
microscopical observations, heparin  was omitted from the  Eagle's medium, which  was 
injected into the peritoneal cavity. 
Cell Counts.  Cells were counted in a standard hemocytometer. Peritoneal and cultured 
mast cells were identified either by staining with neutral red (0.02% in 0.9% NaCI) or by 
using phase contrast microscopy. These methods gave similar results. 
Conditioned  Medium.  Pokeweed  mitogen  (Gibco  Laboratories,  Grand  Island,  NY)- 
stimulated spleen cell-conditioned medium (PWM-SCM) was prepared according to the 
method described in Nakahata et al. (39). Spleen cells were incubated for 5 d at 2 ×  106 
cells/ml in a medium (Flow Laboratories, Irvine, Scotland) containing a 1:300 dilution of 
PWM, 10% fetal bovine serum (Irvine Scientific, Santa Ana, CA), 10 -4 M 2-mercaptoeth- 
anol (Sigma Chemical Co.,  St.  Louis,  MO).  The conditioned  medium was centrifuged, 
filtered through a 0.22 ~tm filter (Millipore Corp., Bedford, MA), and stored at -80°C. 
Culture  of Mast  Cells.  Bone  marrow  cells  were  cultured  at  106/ml  in  a  medium 
supplemented with  10 -4 M  2-mercaptoethanol, 20% horse serum (Sterile Systems, Inc., 
Logan,  UT)  and  10%  PWM-SCM.  Culture  flasks  (Nunc,  Roskilde,  Denmark)  were 
incubated at 37°C in a humidified atmosphere of 5% CO2, 95% air. Half of the medium 
was replaced every 7 d. The cells were washed and resuspended in Eagle's medium for 
injection in vivo. 
Separation  of Peritoneal  Mast  Cells.  The  method  has been  described  in  detail  (40). 
Briefly, most mouse peritoneal cells are macrophages and small lymphocytes. Macrophages 
were removed with a  magnet after being permitted to ingest carbonyl iron (GAF Co., 
New  York).  Small  lymphocytes and  mast cells then  were separated by Percoll density 
gradient centrifugation. After centrifugation, mast cells (30-50% pure) were washed and 
resuspended in Eagle's medium for injection in vivo. 
Cell Injection.  Cultured or peritoneal mast cells were injected into the skin, peritoneal 
cavity, or tail vein of WBB6FI-W/W ~ mice. To facilitate direct injections of cells into the 
skin, an area of dorsal skin was shaved with hair clippers. Cells (in 0.05 ml Eagle's medium 
per site) were injected with a tuberculin syringe. Each mouse received six injections, which 
were  marked  by mixing  India  ink  with  the  suspension  medium.  Intraperitoneal  and 
intravenous injections were done with injection volumes of 0.5 and 0.2 ml, respectively. 
Limiting  Dilution  Analysis  of Mast  Cell Precursors.  The principle of the  method has 1028  IN  VIVO  FATE  OF  CULTURED  MAST  CELLS 
been  described  in  detail  (41).  WBB6F~-W/W v mice  were  killed  5  wk  after  the  direct 
injection of cells into the skin. The dorsal skin was reflected; each injection site that could 
be identified  by the presence  of ink was removed in a  1.5  ×  1 cm piece of skin,  which 
then  was attached  to a  piece of thick filter paper to keep it  flat, and  fixed in  Carnoy's 
fluid (42).  Skin  pieces were embedded  in paraffin;  25-#m-thick serial sections  were cut 
parallel to the skin surface from the subcutaneous tissue to the epithelium, and the sections 
were stained with alcian blue-safranin (42). All of the serial sections were examined under 
the  microscope to detect  mast cell clusters,  defined as a  group of mast cells numbering 
>100  in its largest cross sections.  When at least one mast cell cluster was identified,  we 
assumed  that  the  injected  cell  suspension  had  contained  mast  cell  precursor(s).  The 
concentration of mast cell precursors was calculated from the proportion of injection sites 
at which no clusters appeared (defined as the "proportion of nonappearance") for various 
cell doses by limiting dilution analysis as described by Finney (43), Porter and Berry (44), 
and Breivik (45). 
Assay of Spleen Colony-forming Units (CFU-S).  The method of Till and McCulloch was 
used to determine  the number of CFU-S (46).  Cultured  or peritoneal  ceils of WBB6F1- 
+/+ mouse origin were injected intravenously into syngeneic mice irradiated (850 tad) as 
previously described  (40).  The  mice  were  killed  8  d  after  cell  injection;  spleens  were 
removed and fixed in Bouin's solution, and colonies were counted at a  magnification of 
7× with a dissecting microscope. Each experiment contained at least  10 mice. 
Evaluation of Mast Cell Development, Morphology, and Histochemistry.  Mice were killed 
at various intervals after intraperitoneal  or intravenous injection of cells. Peritoneal cells 
were harvested as described above, and were spun in the cytocentrifuge. A piece of dorsal 
skin, and the spleen and the stomach were removed. The cytocentrifuge preparations and 
the tissues were fixed in Carnoy's fluid. Paraffin sections (10 #m) of tissues were made by 
routine methods and were stained with alcian blue-safranin. Mast cells in the skin, spleen, 
and  glandular  stomach  were  counted  as  described  previously  to  determine  whether 
successful transfer and development of mast cells had occurred (32, 47).  ~105 cells were 
examined in cytocentrifuge preparations of peritoneal cells after staining with alcian blue- 
safranin.  We judged  that  successful  transfer  of mast  cells  to the  peritoneal  cavity had 
occurred if mast cells represented >0.1% of the peritoneal cells. 
Mast Cell Staining with Berberine Sulfate.  In most experiments, representative cytocen- 
trifuge preparations and tissue specimens were stained with the fluorescent dye berberine 
sulfate (Sigma Chemical Co.), as described by Enerbfick (48), and were examined  in an 
epifluorescence microscope (Olympus Corp., Tokyo). Under these conditions of fixation 
and staining,  the  cationic  dye selectively binds  to phosphate- and/or  sulfate-containing 
polyanions, including DNA and heparin (48). However, staining of DNA and heparin are 
distinguishable  because heparin-bound berberine sulfate exhibits rapid fading upon con- 
tinuous  illumination  whereas  DNA-bound dye slowly increases in fluorescence  intensity 
(48).  Furthermore,  when  heparin-containing  mast cells are  examined,  the  cytoplasmic 
granules exhibit bright yellow fluorescence whereas the nucleus appears a dull green (48). 
Dimlich et al. (49) demonstrated  that berberine sulfate staining of tissue sections of rats 
or mice at pH 4.0  identified  connective tissue type mast cells, such as those in the skin. 
By contrast, berberine sulfate did not stain mast cells in the gastric mucosa (49). 
Even though bright cytoplasmic staining with berberine sulfate at pH 4.0 appears to be 
highly selective for heparin-containing  mast cells, we provided further evidence that the 
dye was identifying heparin in our preparations,  by treating some specimens either with 
heparinase  (heparin  lyase from Flavobacterium  heparinum;  Seikagaku  Chemical  Industry 
Co.  Ltd.,  Tokyo)  or  with  chondroitinase  ABC  (chondroitin  ABC  lyase  from  Proteus 
vulgaris;  Seikagaku  Chemical  Industry)  before  staining.  For  treatment  with  enzymes, 
specimens were  fixed in chilled  calcium acetate  formalin at 4°C  for  18 h  according  to 
Yamada (50) and  overlayed with  Tris-HCl  buffer (0.1  M) containing  either  heparinase 
(0.5 IU/ml, pH 7.0) or chondroitinase ABC (5.0 IU/ml, pH 8.0). After washing away the 
enzyme solutions  with  Tris-HCl  buffer  of the  same pH,  specimens  were  stained  with 
berberine sulfate. In control experiments, treatment with heparinase for 30 rain abolished 
the  berberine  sulfate-dependent  fluorescence  of granules  of freshly isolated peritoneal NAKANO  ET  AL.  1029 
mast cells,  whereas treatment with chondroitinase  ABC for 4  h  did not. Treatment of 
specimens with either of the buffer solutions (pH 7.0 or 8.0) alone had no effect on the 
berberine sulfate staining. 
In some cases, mast cells were counted after staining with berberine sulfate, and then 
the same specimens were stained with alcian blue; mast cells in the same optical field were 
counted again, and the ratio of berberine sulfate-positive mast cells to alcian blue-positive 
mast cells was calculated. 
Electron Microscopy.  Cultured cells or peritoneal cells were centrifuged at 500 g for 10 
min. The cell pellets were fixed with 3% glutaraldehyde in 0.I M cacodylate buffer (pH 
7.4) at room temperature for 45  min, and were washed with  0.1  M  cacodylate buffer 
containing 4.5% sucrose. The cells were postfixed with  1% osmium tetroxide in veronal 
acetate buffer (pH 7.4) for 1 h at 4°C, dehydrated in a graded series of ethanol followed 
by acetone, and embedded in Epon 812. Ultrathin sections were cut with an ultramicro- 
tome (LKB Instruments, Inc., Gaithersburg, MD), stained with uranyl acetate and lead 
citrate, and examined with a Hitachi HU-12 electron microscope. 
Histamine Content.  Prior to assay, small aliquots of the  cultured  or peritoneal cells 
were taken to determine the number of mast cells present; the remaining cells were stored 
at -80°C. Histamine concentration was assayed by high performance liquid chromatog- 
raphy coupled with fluorometry as described by Yamatodani et al. (51), and the content 
of histamine per 106 mast cells was calculated. 
Results 
Development of Mast Cells and Mast Cell Precursors in Suspension Culture 
Bone  marrow  cells  of WBB6FI-+/+  mice were  cultured  in  the  presence  of 
10% PWM-SCM.  Aliquots of the cultured cells were harvested when half of the 
medium  was  changed  and  the  concentrations  of CFU-S,  mast cell  precursors, 
and  morphologically  identifiable  mast cells  were  determined.  The  number  of 
CFU-S decreased exponentially, and none were detectable  3  wk after initiation 
of the  culture  (Fig.  1).  By contrast,  the  numbers  of mast cell  precursors  and 
morphologically identifiable mast cells increased rapidly. 4  wk after initiation of 
the culture,  ~2%  of the cultured  cells had the ability to form mast cell clusters 
in the skin ofWBB6F1-W/W v mice, and >95% of the cultured cells were identified 
as immature mast cells (Fig.  1). The immature mast cells stained with alcian blue, 
but with neither safranin or with berberine sulfate (Fig.  2, Table I). 
To  determine  the  concentrations  of mast cell precursors reported  in  Fig.  1, 
WBB6FrW/W ~ recipient  mice  were  killed  5  wk  after  the  direct  cutaneous 
injection of cells harvested 4 wk after the initiation of culture. In one experiment, 
WBB6F~-W/W ~ mice were killed  10 wk after the injection of cultured mast cells. 
Mast cell clusters persisted at the skin injection sites in these mice, and most of 
the mast cells in the clusters stained with berberine sulfate. Some of these mast 
cells also stained with safranin. 
Intraperitoneal Injection of Cultured Mast Cells 
Characteristics of mast cells  recovered from the peritoneal cavity.  Cultured  mast 
cells of WBB6FI-+/+  mouse origin  were harvested 4  wk after the initiation  of 
the culture and 106 cells were injected into the peritoneal cavity of each WBB6Fr 
W/W v mouse.  Peritoneal  cells of the  recipient  mice were  recovered at  various 
times for preparation  of cytocentrifuge specimens or  for electron  microscopy. 
Mast cells that stained with berberine sulfate were observed 3 wk after intraper- 
itoneal  injection  and,  by  10  wk,  accounted  for  ~90%  of the  recovered  cells 1030  IN  VIVO  FATE  OF  CULTURED  MAST  CELLS 
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FIGURE  1.  Concentrations of total cells, morphologically identifiable mast cells, CFU-S, and 
mast cell precursors, at various times after the initiation of suspension culture of WBB6F~-+/ 
+  mouse bone marrow cells (10S/ml) in  10%  PWM-SCM.  Cells were fed by replacement of 
half of the medium every week; cell concentrations were determined at that time. 
(Table  I,  Fig.  2).  Berberine  sulfate  staining  of the  recovered  mast  cells  was 
prevented by first incubating the cells with 0.5 IU/ml of heparinase for 30 min 
(Fig. 2). By contrast, incubation of the cells with the heparinase buffer solution, 
or with 5  IU/mi of chondroitinase ABC for 4 h, did not significantly affect the 
intensity of berberine sulfate staining (Fig. 2). 
In addition to acquiring the ability to stain with berberine sulfate, the recovered 
cells exhibited other alterations in phenotype when compared with cultured mast 
cells  studied  before  adoptive  transfer.  Thus,  mast  cells  studied  10  wk  after 
intraperitoneal  injection stained with safranin and exhibited ultrastructural  fea- 
tures  similar  to  those of mature  peritoneal  mast  cells recovered from  normal 
WBB6Fv+/+ mice (Fig. 2). Moreover, mast cell histamine content progressively 
increased after intraperitoneal  injection (Table I). 
Two  experiments  were  done  to  exclude  the  possibility that  intraperitoneal 
injection of cultured  mast cells might  induce the development of mast cells of 
WBB6F1-W/W  v (recipient) origin.  First, we injected cultured mast cells (106)  of 
C57BL/6-gbJ/bg J mouse origin into the peritoneal cavity ofWBB6FI-W/W  v mice. 
10 wk after injection, most of the mast cells stained with berberine sulfate and 
many of them stained with safranin.  All of the recovered mast cells exhibited the 
giant cytoplasmic granules characteristic of the bgJilbg J mutation. 
For the  second experiment,  bone marrow  cells of either  WBB6FwW/W  v or NAKANO  ET  AL.  1031 
FIGURE  2.  (A-D) Cytocentrifuge preparations stained with berberine sulfate. (A) Cultured 
mast cells 4  wk after initiation of culture; only nuclei showed faint fluorescence. ×  400. (B) 
Peritoneal  cells  recovered  from  a  WBB6F1-W/W  v  mouse  10  wk  after  the  intraperitoneal 
injection of 10 e cultured mast cells of WBB6FI-+/+ mouse origin. The cytoplasm of the mast 
cells exhibited intense fluorescence. ×  400. (C) A specimen made from the same cell suspension 
shown in B, but treated with chondroitinase ABC before staining. Bright cytoplasmic fluores- 
cence of mast cells was retained. ×  200. (D) A specimen made from the same cell suspension 
shown in B and C, but treated with heparinase before staining. Heparinase treatment abolished 
staining of mast cells by berberine sulfate. X 200. (E) The ultrastructure of a  cultured mast 
cell 4  wk after initiation of the culture. The cytoplasmic granules exhibited heterogeneous 
content. ×  5,800. (F) Ultrastructure of a  mast cell recovered from the peritoneal cavity of a 
WBB6FrW/W ~ mouse  10  wk  after  intraperitoneal  injection  of  cultured  mast  cells.  The 
cytoplasmic granules appear uniformly electron dense. ×  5,800. 1032  IN  VIVO  FATE  OF  CULTURED  MAST  CELLS 
TABLE  I 
Proportion of Berberine Sulfate-positive Cells and Histamine Content 
of Mast Cells Recovered  from the Peritoneal Cavity of WBB6F  I-W/W  ~ 
Mice After Intraperitoneal Injection of 108 Cultured Mast Cells of 
WBB6F  I-+  / + Mouse Origin 
Type of cells 
Berberine sulfate- 
positive cells as a 
percent of alcian 
blue-positive cells* 
Histamine content of 
peritoneal cells* (ng/ 
106 mast cells) 
Cultured mast cells 
Before i.p. injection  <0.1' (7)  120 __. 9 (4) 
1 wk after  <0.1 * (7)  430 ±  100 (4) 
3 wk after  5 ±  1 (6)  i  470 +  130 (7) 
5 wk after  60 ±  11 (5)  !  1,540 ±  310 (6)  ! 
10 wk after  93 ±  3 (I0)  !  2,730 ±  140 (8)  ! 
Peritoneal mast cells of  98 ±  5 (5)  13,800 ±  2,100 (7)  0 
WBB6FI-+/+ mice 
* Mean ±  SE; number of mice is shown in parenthesis. 
* No berverine sulfate-positive cells seen in >1,000 alcian blue-positive 
cells. 
! p  <  0.01, when compared with the value listed above by t test. 
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FIGURE 3.  Comparison  of  in  vitro  growth  of cultured  mast  cells  of WBB6F~-W[W" or 
WBB6Ft-+/+ mouse origin. Cultured mast cells were harvested 4  wk after initiation of the 
original cultures, which had been maintained in medium supplemented with 10% PWM-SCM. 
The W/W"  or +/+ cells were then incubated (3.0 x  104 cells/ml) with various concentrations 
of PWM-SCM for 1 wk, after which the number of mast cells was determined. 
WBB6FI-+/+ mice were cultured in the presence of PWM-SCM. As was reported 
by Yung and Moore (7), mast cells developed in both cultures. Like WBB6F]-+/ 
+  cells, cultured mast cells of WBB6F]-W/W  ~ origin stained with alcian blue but 
with neither safranin  or berberine sulfate.  4  wk after the initiation  of culture, 
we compared the growth response of the two populations by placing the cells in 
various concentrations  of PWM-SCM.  No  significant  differences between the 
responses of WBB6F]-W/W  ~ and -+/+ cells were observed (Fig. 3). Although the 
experiment shown in Fig. 3 used PWM-SCM prepared with WBB6FI-+/+ cells, 
an experiment using PWM-SCM prepared with WBB6Fx-W/W  v cells gave similar 
results (data not shown). 
In striking contrast to the results obtained in vitro, marked differences in the 
behavior  of WBB6F1-W/W  ~ and  -+/+  cells were observed when  the  cultured 
mast cells were injected in vivo (Table II). Indeed, no mast cells of WBB6Ft-W/ NAKANO  ET  AL.  1033 
TABLE II 
Disappearance of Cultured Mast Cells of WBB6F  rW]W  ~  Mouse 
Origin After Transplantation into the Peritoneal Cavity of 
WBB6FrW/W  ~  Mice 
Weeks after  Genotype of  No. of re-  No. of mast cells per 
10  s peritoneal 
injection  cultured cells  cipients  nucleated cells* 
1  +/+  4  23.2 + 6.9 
W/W  ~  6  2.5 -  0.6* 
3  +/+  6  26.3 -  3.5 
W/W  ~  7  0.6 -  0.3* 
5  +[+  6  22.3 -  2.7 
W/W  ~  7  <0.1' 
10  +[+  4  27.5 -+ 2.8 
W/W"  7  <0.1' 
Cultured  mast cells were injected intraperitoneally  into WBB6FrW/W ~ 
recipients  (106 cells per mouse) 4  wk after the  initiation  of the cell 
cultures. 
* The results are shown as the mean + SE. 
*P < 0.01, when compared with the value for +/+ mice by t test. 
W ~ origin were detectable  3 wk after intraperitoneal  injection, and no mast cells 
that stained with safranin or berberine sulfate were detected at any intervals. 
Tissue Distribution and Characteristics of Mast Cells Recovered after 
Intraperitoneal Injection of Cultured or Peritoneal Mast Cells 
To determine whether mast cells injected intraperitoneally might migrate to 
other  anatomical  sites,  we  injectd  cultured  mast cells  of WBB6Fr+/+  mouse 
origin into the peritoneal cavity of WBB6F~-W/W  v mice, and searched for mast 
ceils in various tissues of these mice 10 wk later. Partially purified (30-50% pure) 
peritoneal  mast cells,  which,  like  our preparations  of cultured  mast cells,  con- 
tained  no  detectable  CFU-S  (data  not  shown),  were  injected  for  comparison. 
Injection of either cultured or peritoneal mast cells resulted in the development 
of mast cells in the peritoneal cavity, spleen, skin, and glandular stomach (Table 
III). Mast cells were detected more frequently in the muscularis propria; most of 
them were situated in the outer layer of the muscle. 
Most mast cells in the peritoneal  cavity, spleen,  skin,  and  muscularis propria 
of the  stomach were stained  with berberine  sulfate,  and  some of them  stained 
with safranin. By contrast, when mast cells were observed in the stomach mucosa, 
they stained only with alcian blue. In occasional sections, mast cells were observed 
in  both  the  muscularis  propria  and  the  mucosa.  In  these  stomachs,  berberine 
sulfate- or safranin-positive mast cells were observed only in the muscularis. 
Tissue Distribution and Characteristics of Mast Cells Observed After 
Intravenous Injection of Cultured or Peritoneal Mast Cells 
10  wk  after  intravenous  injection  of  cultured  or  peritoneal  mast  cells  of 
WBB6F~-+/+  origin,  mast cells were observed in the peritoneal  cavity, spleen, 
skin,  and  glandular  stomach  of recipient  WBB6Fl-W/W  v mice (Table  IV).  As 
with  intraperitoneal  injections  of  cells,  most  of  the  mast  cells  observed  in 1034  IN  VIVO  FATE  OF  CULTURED  MAST  CELLS 
TABLE  Ill 
Appearance  of Mast Cells in WBB6FrW/W  v Mice 10 Wk After Intraperitoneal Injection  of 
Cultured or Peritoneal Mast Cells of WBB6F  r+/  + Mouse Origin 
Proportion of cases in which mast cells appeared 
Type of mast  No. of 
cells  cells  Peritoneal  Glandular stomach 
cavity  Spleen  Skin  Muscle  Mucosa 
Cultured*  lO  2  0/5  0/5  0/5  0/5  0/5 
lO  3  2/5  0/5  0/5  3/5  0/5 
10  4  5/6  0/6  0/6  5/6  2/6 
l0  b  6/6  1/6  1/6  5/6  4/6 
Peritoneal*  10  3  2/10  o/lo  0/10  0/10  0/10 
10  4  6/9  0/9  3/9  4/9  1/9 
lO  s  lO/lO  lO/lO  3/10  9/10  5/10 
* Cultured mast cells were harvested 4 wk after the initiation of the culture. 
* Peritoneal mast cells were partially purified (30-50%); the number shown in the table refers to the 
number of mast cells injected. 
TABLE  IV 
Appearance of Mast Cells in WBB6FrW/W  ~  Mice 10 Wk After Intravenous Injection of 
Cultured or Peritoneal Mast Cells of WBB6F  I-+/+ Mouse Origin 
Proportion of cases in which mast cells appeared 
Type of mast  No. of 
cells  cells  Peritoneal  Glandular stomach 
cavity  Spleen  Skin  Muscle  Mucosa 
Cultured*  103  0/6  1/6  0/6  0/6  0/6 
104  0/5  1/5  0/5  0/5  0/5 
105  0/6  5/6  0/6  1/6  1/6 
l0  s  1/6  6/6  2/6  5/6  5/6 
Peritoneal*  10  3  0/8  3/8  0/8  0/8  0/8 
10  4  0/8  6/8  0/8  1/8  1/8 
lO  5  6/6  6/6  0/6  5/6  5/6 
* Cultured mast cells were harvested 4 wk after the initiation of the culture. 
* Peritoneal mast cells were partially purified (30-50%); the number shown in the table refers to the 
number of mast cells injected. 
connective tissue sites stained with berberine sulfate and some of them stained 
with safranin. But in the glandular stomach, berberin sulfate- or safranin-positive 
mast cells were observed only in  the  muscularis propria;  all  mast cells  in  the 
mucosa  stained  only with  alcian  blue  (Fig.  4).  Intravenous injection of cells 
resulted in the more frequent development of mast cells in the spleen than in 
the peritoneal cavity or stomach (Table IV).  The opposite was true when cells 
were injected intraperitoneally (Table III). Intravenous injection of cultured or 
peritoneal mast cells had no measurable effect on the macrocytic anemia of the 
recipient WBB6FrW/W  ~ mice (data not shown). 
Discussion 
The mast cells that developed in suspension cultures of mouse bone marrow 
cells  supplemented with  PWM-SCM  resembled  the  growth factor-dependent NAKANO  ET  AL.  1035 
FIGURE 4.  Glandular stomach of a WBB6F1-W[W  ~ mouse fixed 10 wk after the intravenous 
injection of 106 cultured  mast cells of WBB6Fw+/+  mouse origin.  The cultured  mast cells 
had been harvested for injection 4 wk after initiation of the culture. (A) Stained with alcian 
blue-safranin.  Many mast cells stained with alcian blue were observed in the mucosa. The area 
indicated by the arrow is shown in higher magnification in B. (C) The same section stained 
with berberine sulfate; only mast cells in the muscle layer showed bright cytoplasmic fluores- 
cence. The area indicated by the arrow is shown in higher magnification D. (A and C) x  100. 
(B and D) x  1,000. 
mast cells characterized in the laboratory of S. J. Galli (1,  2,  15) and by several 
other investigators (5-7,  10,  12-14,  16-18, 39, 52). The cells had the ultrastruc- 
tural  features  of immature  mast  cells,  contained  low  levels  of histamine,  and 
synthesized cytoplasmic granules  that  stained  with alcian  blue but  with  neither 
safranin or with berberine sulfate. We found that, as the number of morpholog- 
ically identifiable mast cells in the cultures increased, the number of cells capable 
of giving rise to mast cell clusters when injected into the skin of WBB6FI-W/W  v 
mice increased  roughly in parallel.  Such  mast cell precursors represented  ~1% 
of the cells present 4-5 wk after the initiation of culture. By contrast, the number 
of  CFU-S  decreased  exponentially,  and  none  were  detectable  after  3  wk  of 
culture. 
Mast cell clusters were identifiable in the skin of WBB6F1-W/W  v mice examined 
even  10  wk after intracutaneous  injection  of the  cultured  cells.  Some of these 
mast cells stained with safranin and most of them stained with berberine sulfate, 
a pattern mimicking that of normal cutaneous mast cells of the connective tissue- 
type (21,  48,  49).  By contrast,  Crapper et al. (29) found that cultured mast cells 
derived  from  B10.D2  or  C57BL/6J-bgJ/bg J  mice did  not  survive >2  wk  after 
injection  into  the  skin  of BIOD2F1-Wf/W f  mice.  If the  recipient  mice  bore  a 
subcutaneous  inoculum  of the  IL-3-producing WEHI-3B tumor, mast cells sur- 1036  IN  VIVO  FATE  OF  CULTURED  MAST  CELLS 
vived in the skin for 4 wk after injection (29).  But these mast cells stained only 
with alcian blue; no safranin-positive mast cells were observed. 
The discrepancy between our results and those of Crapper et al. (29) may be 
attributable  to  differences  in  the  host  animals.  The  mast  cell  deficiency  of 
BIOD2FI-WY/W  y mice is not as severe as that of WBB6F~-W/W" mice (29).  We 
found that,  when  mast cell precursors  of C57BL/6-bgJ/bg J  mouse origin  were 
injected into the skin of different mice doubly heterozygous for mutations at the 
W locus (e.g., WBB6F1-W"/W  j, -W"/W  ~h, and -W/W~), the frequency of develop- 
ment and size of mast cell clusters were inversely proportional to the concentra- 
tion of mast cells in the skin of the host mice (unpublished data). Whatever the 
explanation for the differences between our findings and those of Crapper et al. 
(29), our data indicate that exogenous sources of IL-3 or other growth factors 
are not required for the survival of cultured WBB6F~-+/+ mast cells in WBB6F~- 
W/W ~ mice. In addition,  our histochemical findings indicate that cultured mast 
cells injected directly into the skin of WBB6F~-W/W v mice acquire at least some 
of the characteristics of mature CTMC. 
An analogous result was obtained when cultured mast cells were injected into 
the peritoneal cavity of WBB6Fa-W/W ~ mice. Many of the mast cells recovered 
5 wk after intraperitoneal injection of cultured cells were safranin and berberine 
positive; by  10  wk,  ~90%  of the  mast cells stained  with  berberine  sulfate.  In 
addition,  the  histamine  content  of the  recovered  mast  cells was  substantially 
increased  compared  with  that  of cells  taken  directly  from  culture,  and  the 
recovered cells closely resembled normal mature peritoneal mast cells by ultra- 
structure (53). 
Two lines of evidence indicate that the mast cells recovered from the peritoneal 
cavity of recipient WBB6F1-W/W ~ mice were derived from the injected cultured 
ceils.  First,  when  the  experiment  was performed  using cultured  mast  cells of 
C57BL/6-bgJ/bg J origin, the mast cells recovered 10 wk later contained the giant 
cytoplasmic granules characteristic of the beige mutation. Second, when cultured 
mast  cells derived  from  WBB6FI-W/W ~ mice  were  injected,  identifiable  mast 
cells  were  no  longer  present  5  wk after  intraperitoneal  injection.  The  latter 
finding argues against the notion that the mast cell recovered from the peritoneal 
cavity of WBB6F1-W/W ~ mice injected with cultured mast cells of WBB6FI-+/+ 
origin, were of host origin. 
The differences in the behavior of WBB6F~-W/W ~ and -+/+  mast cells after 
injection into WBB6F~-W/W ~ mice are of interest.  Even though  cultured mast 
cells  derived  from  WBB6F~-W/W ~  or,  -+/+  bone  marrow  cells  gave  similar 
responses to growth factors present in  PWM-SCM when tested 4  wk after the 
initiation  of culture,  the WBB6F~-W/W ~ mast cells could not survive as well as 
WBB6F~-+/+ cells after injection in vivo. This result may reflect a defect in the 
ability of cultured mast cells of WBB6F~-W/W ~ origin to respond to growth or 
differentiation factors present in vivo but not in vitro. On the other hand, Yung 
and Moore (7) reported that cultured mast cells of WBB6F1-W/W ~ origin survive 
in culture less well than  control cells of WBB6F~-W/+ origin,  with differences 
between these  populations  first  evident at  about  5  wk of culture.  This  result 
raises the possibility that the disappearance of WBB6F~-W/W ~ cells in vivo may NAKANO  ET  AL.  1037 
have occurred as a result of an intrinsic cellular defect that can also be expressed 
in vitro. 
The phenotype of mast cells developing in the tissues of recipient mice after 
intravenous  or intraperitoneal  transfer of cultured  cells varied predictably ac- 
cording  to  anatomical  site.  Many  mast  cells in  the  skin,  spleen,  or peritoneal 
cavity of recipient WBB6F2-W/W  ~ mice stained with berberine sulfate, and some 
of them stained with safranin.  These cells thus resembled by histochemistry the 
resident populations of CTMC observed at these sites in normal +/+ mice. The 
same was true when the histochemistry of mast cells developing in the stomachs 
of recipient  WBB6FI-W/W  ~  mice  was  considered.  Like  the  mast  cells  in  the 
mucosa of the glandular  stomach of +/+ mice, the mast cells that developed in 
the  gastric  mucosa  of recipient  WBB6F~-W/W  ~  mice  stained  only with  alcian 
blue;  none  of the  cells  stained  with  either  safranin  or  berberine  sulfate.  By 
contrast, many of the mast cells developing in the glandular stomach muscularis 
propria of recipient WBB6F~-W/W  v mice stained with safranin and with berber- 
ine sulfate. 
Enerb/ick  (48)  and  Dimlich  et  al.  (49)  demonstrated  that  berberine  sulfate 
staining  is  highly  specific for  heparin-containing  mast  cells  of the  connective 
tissue  type.  We  confirmed  the  specificity of the  reaction  in  our  material  by 
demonstrating  that  the  staining  was prevented  by prior  treatment  of the cells 
with  heparinase  but not chondroitinase  ABC.  These  findings  strongly suggest 
that  cultured  mast cells or their  progeny acquire  the ability to synthesize and 
store heparin when they are transplanted  to appropriate anatomical locations in 
vivo. This represents an important observation, since under usual conditions of 
suspension culture (2,  10,  17,  19), or even when exposed to the inducing agent 
sodium butyrate (2), mouse mast cells synthesize chondroitin sulfates rather than 
heparin.  It should be acknowledged, however, that histochemistry represents an 
indirect approach to the identification of cellular constituents.  It therefore will 
be  important  to  use  direct  biochemical  methods  to  confirm  the  presence  of 
heparin  in the mast cells. Evaluations of other aspects of the phenotype of the 
recovered  cells,  such  as  expression  of membrane  structures  characteristic  of 
cultured  as  opposed  to  normal  peritoneal  mast  cells  (10,  54)  will  also  be  of 
interest. 
Taken together, our histochemical and ultrastructural evidence indicates that, 
after injection  into  WBB6F1-W/W  ~ recipients,  cultured  mast cells and/or  their 
progeny are able to acquire characteristics of either CTMC or MMC. Whether 
such  phenotypic  plasticity  is  a  property  of all  cultured  mast  cells,  or  only  a 
subpopulation, remains to be determined. Whatever the answer to this question 
may be, our observations argue against the notion that cultured mouse mast cell 
populations maintained under ordinary in vitro conditions are irrevocably com- 
mitted to the MMC phenotype. 
Several mechanisms might account for the expression of the two murine mast 
cell phenotypic patterns  recognized in our experiments.  One possibility is that 
the cultured cells (and immature mast cells in vivo) contain or can generate two 
distinct committed lineages, one of which gives rise to cells with the phenotype 
of MMC,  the  other  of which  gives  rise  to  CTMC.  Certain  complex  culture 
systems containing embryonic fibroblasts permit the expression of two mast cell 1038  IN  VIVO FATE OF  CULTURED MAST CELLS 
phenotypic patterns in vitro (55). However, ifcommittment to two separate mast 
cell lineages occurred in our experiments,  it probably happened  in vivo. First, 
cultured mast cell populations, even when not cloned, for the most part exhibit 
remarkably uniform characteristics (reviewed in 15). Expression of type II major 
histocompatibility complex (MHC) products may vary, but probably in response 
to differences in  levels  of soluble factors  such  as  y-interferon  (2,  5,  15,  56). 
Second, in a recent collaborative study with Dr. T. Nakahata and his colleagues 
at Shinshu University, Matsumoto, Japan, we injected cloned mast cells derived 
from individual methylcellulose colonies into both the skin and the gastric mucosa 
of WBB6F~-W/W v mice (manuscript in preparation).  The mast cells that devel- 
oped in the skin expressed the histochemical characteristics of CTMC, whereas 
the  mast  cells developing in  the  gastric  mucosa stained  only with alcian  blue. 
This result indicated that each clone contained cells capable of generating both 
mast cell phenotypes. 
However, the occurrence of phenotypically distinct mast cell populations does 
not necessarily require the existence of distinct mast cell lineages.  For example, 
a single lineage might give rise to populations whose phenotype varied according 
to such  factors as  stage  of differentiation/maturation,  anatomical  location,  or 
state of functional activity (15, 57). Our investigation of the development of mast 
cells  after  intraperitoneal  or  intravenous  injection  of representative,  freshly 
isolated CTMC suggests that the phenotypic pattern ordinarily expressed by an 
individual mast cell population in vivo can be altered if those cells are transferred 
to a different anatomical location. 
After intravenous  or intraperitoneal  injection  of partially  purified  (30-50% 
pure) peritoneal mast cells, we observed mast cells in both the connective tissues 
and gastric mucosa of WBB6F~-W/W ~ recipients.  Remarkably, the mast cells in 
the  gastric  mucosa  stained  only  with  alcian  blue.  The  CFU-S  represents  a 
precursor of the  mast cell lineage (32,  47),  but normal  mouse peritoneal  mast 
cells can exhibit extensive proliferative potential when injected intracutaneously 
into WBB6FI-W/W ~ mice (40). Taken together,  these observations suggest that 
the alcian  blue-positive mast cells in  the  gastric  mucosa were actually derived 
from  the  injected  peritoneal  mast  cells,  and  raises  the  possibility that,  under 
certain circumstances, CTMC give rise to cells with at least some of the features 
of MMC. The extent of alteration of peritoneal mast cell phenotype associated 
with location of the cells in the gastric mucosa, and the mechanisms regulating 
such changes, are currently under investigation. 
In addition to their relevance to the controversy about mast cell subsets, our 
observations suggest a  new approach to the analysis of mast cell function.  Mast 
cell-deficient mice represent a useful model for the analysis of mast cell biology 
in  vivo.  However, mast  cell-deficient  mice and  their  normal  +/+  littermates 
differ in characteristics other than the number of mast cells:  mast cell-deficient 
mice of W/W v genotype are anemic, sterile, and lack cutaneous melanocytes (3 I). 
Adoptive  transfer  of  WBB6F~-+/+  bone  marrow  into  WBB6F~-W/W v  mice 
produces an animal (+/+ --0 W/W v) whose mast cell defect is largely corrected, 
but whose anemia is cured as well (31, 32). Under certain circumstances, it may 
be difficult to determine whether an alteration of a particular biological response 
in +/+ --~ W/W ~ mice reflects the reconstitution  of mast cells, normalization  of NAKANO  ET  AL.  1039 
the hematocrit,  or some other effect of transplantation  of unfractionated  bone 
marrow  cells.  However,  cultured  mast  cell  populations  exhibit  much  more 
stringent lineage committment than do normal bone marrow cells. When tested 
after several weeks in vitro they contained undetectable levels of CFU-S (present 
study) or erythroid burst-forming  units  (BFU-E) (H.  Steinberg and S. J.  Galli, 
unpublished data).  Furthermore,  injection of cultured mast cells into WBB6F~- 
W/W  ~ mice  partially  reconstituted  mast  cell  populations  without  having  any 
measurable effect on the recipient animals'  macrocytic anemia.  Transplantation 
of cultured mast cells into WBB6Fj-W/W' mice thus may represent an attractive 
strategy for selectively reconstituting the mast cell compartment of these animals. 
Summary 
Both  connective  tissue mast  cells and  mast cells grown  in  vitro are derived 
from muhipotential hematopoietic stern cells, but these two mast cell populations 
exhibit many differences in morphology, biochemistry, and function. We inves- 
tigated whether the phenotype of cultured mast cells or their progeny was altered 
when the cells were transferred  into different locations in vivo. Cultured  mast 
cells were  immature  by ultrastructure,  and  stained  with  alcian  blue but  with 
neither safranin or berberine sulfate, a fluorescent dye that binds to the heparin 
of connective tissue mast cell granules.  By contrast,  mast cells recovered from 
the peritoneal cavity of congenitally mast cell-deficient (WB ×  C57BL/6)F1-W/ 
W v  (WBB6F1-W/W  ~)  mice  10  wk  after  intraperitoneal  injection  of cultured 
WBB6FI-+/+  or  C57BL/6-bgJ/bg  J  mast  cells  stained  with  both  safranin  and 
berberine sulfate. Staining with berberine sulfate was prevented by treatment of 
the  cells  with  heparinase  but  not  chondroitinase  ABC,  suggesting  that  the 
adoptively transferred mast cell population had acquired the ability to synthesize 
and store heparin.  Furthermore, the recovered mast cells were indistinguishable 
by uitrastructure from the normal mature peritoneal mast cells of WBB6F1-+/+ 
mice, and contained substantially more histamine than mast cells studied directly 
from culture. 
Intravenous  injection  of cultured  mast  cells resulted  in  the  development  of 
safranin- and berberine sulfate-positive mast cells in the peritoneal cavity, spleen, 
skin, and glandular stomach muscularis propria. Mast cells also developed on the 
glandular  stomach mucosa, but these cells stained with alcian blue rather  than 
safranin,  and  did  not  stain  with  berberine  sulfate.  This  result  suggests  that 
cultured mast cells can give rise to mast cells of either the connective tissue type 
or mucosal phenotype, depending  on anatomical  location.  Furthermore,  trans- 
plantation  of cultured  mast cells into  WBB6F~-W/W  ~ mice had  no measurable 
effect on  the anemia  of the  recipient  mice,  suggesting  a  possible strategy  for 
repairing the mast cell deficiency of WBB6F~-W/W  ~ mice without affecting other 
bone marrow-derived populations such as erythrocytes. 
Intravenous injection of representative connective tissue type mast cells (30- 
50%  pure peritoneal  mast cells derived from  WBB6Fl-+/+  mice) gave results 
similar to those obtained with cultured  mast cells: mast cells developing in the 
peritoneal  cavity,  skin,  spleen,  and  glandular  stomach  muscularis  propria  of 
WBB6F1-W/W  ~ recipients stained  with safranin  and berberine sulfate, whereas 
mast cells developing in the mucosa of the glandular  stomach stained only with 1040  IN  VIVO  FATE  OF  CULTURED  MAST  CELLS 
alcian  blue.  This  result  offers  further  support  to  the  notion  that  mast  cell 
phenotype may be regulated, at least in part, by the tissue microenvironment. 
We acknowledge the valuable discussions with Drs. S. Suzuki and Y. Nakanishi of Nagoya 
University and Dr. G. Eguchi of the National Institute of Basic Biology. 
Received for publication 4 June 1985. 
References 
1.  Nabel, G., S.J. Galli, A. M. Dvorak, H. F. Dvorak, and H. Cantor.  1981. Inducer T 
lymphocytes synthesize a  factor that  stimulates proliferation of cloned  mast cells. 
Nature (Lond.).  291:332. 
2.  Galli, S.J., A. M. Dvorak, J. A. Marcum, T. Ishizaka, G. Nabel, H. Der Simonian, K. 
Pyne, J. M. Goldin, R. D. Rosenberg, H. Cantor, and H. F. Dvorak. 1982. Mast cell 
clones: a model for the analysis of cellular maturation. J. Cell Biol. 95:435. 
3.  Yokota, T., F. Lee, D. Rennick, C. Hall, N. Arai, T. Mosman, G. Nabel, H. Cantor, 
and  K.  Arai.  1984.  Isolation and  characterization  of a  mouse  cDNA  clone  that 
expresses mast-cell growth-factor activity in monkey cells. Proc. Natl. Acad. Sci.  USA. 
81:1070. 
4.  Rennick,  D.,  F.  D.  Lee, T.  Yokota, K.-I. Arai,  H. Cantor, and G.  Nabel.  1985.  A 
cloned MCGF cDNA encodes a multilineage hematopoietic growth-factor: multiple 
activities of interleukin 3. J. Immunol.  134:910. 
5.  Tertian, G., Y.-P.  Yung,  D. Guy-Grand, and M. A. S. Moore.  1981.  Long-term in 
vitro culture of murine mast cells. I. Description of a growth-factor dependent culture 
technique.J. Immunol.  127:788. 
6.  Yung,  Y.-P.,  R.  Eger,  G. Tertian, and  M.  A.  S.  Moore.  1981.  Long-term in vitro 
culture  of murine  mast cells.  II. Purification  of a  mast cell  growth-factor and  its 
dissociation from TCGF.J. Immunol.  127:794. 
7.  Yung, Y.-P., and M. A. S. Moore.  1982.  Long-term in vitro culture of murine mast 
cells. III. Discrimination of mast cell growth-factor and granulocyte CSF. J. Immunol. 
129:1256. 
8.  Yung,  Y.-P.,  and  M.  A.  S.  Moore.  1983.  Mast cell growth-factor. Lymphokine  Res. 
2:127. 
9.  Ihle, J. N., J. Keller, S. Oroszlan, L. E.  Henderson T. D. Copeland, F.  Fitch, M.  B. 
Prystowsky, E.  Goidwasser, J.  W.  Schrader,  E.  Palaszynski,  M.  Dy, and  B.  Lebel. 
1983.  Biological  properties  of homogeneous  interleukin  3.  I.  Demonstration  of 
WEHI-3 growth-factor activity, mast cell growth-factor activity, P  ceil-stimulating 
factor activity, colony-stimulating factor activity, and histamine-producing cell-stim- 
ulating factor activity. J. Immunol.  131:282. 
10.  Razin, E.,J. N. Ihle, D. Seldin, J. M. Mencia-Huerta, H. R. Katz, P. A. LeBlank, A. 
Hein, J.  P.  Caulfield,  K.  F.  Austen,  and  R.  L.  Stevens.  1984.  Interleukin  3:  a 
differentiation and growth factor for the mouse mast cell that contains chondroitin 
sulfate E proteoglycan. J. Immunol.  132:1479. 
11.  Fung,  M.  C., A.J.  Hapel, S. Ymer, D.  R. Cohen,  R. M. Johnson,  H. D. Campbell, 
and I. G. Yung.  1984. Molecular cloning of cDNA for murine interleukin-3. Nature 
(Lond.).  307:233. 
12.  Schrader, J. W., S.J. Lewis, I. Clark-Lewis, andJ. G. Culvenor. 1981. The persisting 
(P) cell: histamine content, regulation by a T  cell-derived factor, origin from a bone 
marrow precursor, and relationship to mast cells. Proc. Natl. Acad. Sci.  USA.  78:323. 
13.  Schrader, J.  W.  1981.  The in  vitro  production  and  cloning of the  P  cell,  a  bone NAKANO  ET  AL.  1041 
marrow-derived null cell that expresses H-2 and Ia-antigen, has mast cell-like gran- 
ules, and is regulated by a factor released by activated T  cells. J. Immunol.  126:452. 
14.  Schrader, J. w.  1983. Bone marrow differentiation in vitro. CRC Crit.  Rev. Immunol. 
4:197. 
15.  Gaili,  S.  J.,  A.  M.  Dvorak,  and  H.  F.  Dvorak.  1984.  Basophils  and  mast  cells: 
morphologic insights into their biology, secretory patterns, and function. Prog. Allergy. 
34:1. 
16.  Nagao, K., K. Yokoro, and S. A. Aaronson. 1981. Continuous lines of basophil/mast 
cells derived from normal mouse bone marrow. Science (Wash. DC). 212:333. 
17.  Sredni, B., M. M. Friedman, C. E. Bland, and D. D. Metcalfe.  1983. Ultrastructural, 
biochemical and functional characteristics of histamine-containing cells cloned from 
mouse  bone  marrow:  tentative  identification  as  mucosal  mast  cells. J.  Immunol. 
131:915. 
18.  Razin, E., C. Cordon-Cardo, and R. A. Good. 1981. Growth of a pure population of 
mouse mast cells  in vitro  with conditioned medium derived from concanavalin A- 
stimulated splenocytes. Proc. Natl. Acad. Sci. USA.  28:2559. 
19.  Razin, E.,  R.  L. Stevens, F. Akiyama, K. Schmidt, and K. F. Austen.  1982.  Culture 
from mouse bone marrow of a subclass of mast cells possessing  a distinct chondroitin 
sulfate proteoglycan with glycosaminoglycans rich in N-acetylgalactosamine-4,6-di- 
sulfate.J. Biol. Chem..257:7229. 
20.  Maximow, A. 1906. Llber die Zellformen des lockeren Bindegewebes. Arch. Mikrosk. 
Anat. Entwicklungsmech.  67:680. 
21.  Enerbfick, L.  1981. The gut mucosal mast cell. Monogr. Allergy 17:222. 
22.  Befus,  A.  D.,  F.  L.  Pearce, J.  Gauldie,  P.  Horsewood, and J.  Bienenstock.  1982. 
Mucosal mast cells.  I. Isolation and functional characteristics of rat intestinal  mast 
cells.J. Immunol.  128:2457. 
23.  Tas, J., and R. G. Bernsden.  1977. Does heparin occur in mucosal mast cells of the 
rat small intestine?J. Histochem.  Cytochem.  25:1058. 
24.  Haig, D. M., T. A. McKee, E. E. E. Jarrett, R. Woodbury, and H. R. P. Miller.  1982. 
Generation of mucosal mast cells is stimulated in vitro by factors derived from T cells 
of helminth-infected rats. Nature (Lond.). 300:188. 
25.  Mayrhofer, G. 1980. Thymus-dependent and thymus-independent subpopulations of 
intestinal  intraepithelial  lymphocytes. A  granular subpopulation of probable bone 
marrow origin and relationship to mucosal mast cells. Blood. 55:532. 
26.  Jarrett,  E.  E.  E.,  and  H.  R.  P.  Miller.  1982.  Production and  activities  of IgE in 
helminth infections. Prog. Allergy.  31:178. 
27.  Guy-Grand, D.,  M.  Dy,  G.  Luffau, and  P.  Vassali.  1984.  Gut mucosal mast cells: 
origin, traffic, and differentiation..]. Exp. Med.  160:12. 
28.  Ruitenberg, E. J., and A. Elgersma.  1976. Absence of intestinal mast cell response in 
congenitally  athymic  mice  during  TrichineUa  spiralis  infection.  Nature  (Lond.). 
264:258. 
29.  Crapper, R. M.,  W. R. Thomas, J. W. Schrader.  1984. In vivo transfer of persisting 
(P) cells: further evidence for their identity with T-dependent mast cells. J. lmmunol. 
133:2174. 
30.  Galli,  S. J., A. M.  Dvorak, J. A. Marcum, T.  Ishizaka, G.  Nabel, H. Der Simonian, 
K., Pyne, J. M. Goldin, R. D. Rosenberg, H. Cantor, and H. F. Dvorak. 1983. Mouse 
mast cell clones. Modulation of functional maturity in vitro. Monogr. Allergy.  18:166. 
3 I.  Kitamura, Y., S.  Go, and K. Hatanaka.  1978. Decrease of mast cells in W/W  ~ mice 
and their increase by bone marrow transplantation. Blood.  52:447. 
32.  Kitamura,  Y.,  M.  Shimada,  S.  Go,  H.  Matsuda,  K.  Hatanaka, and  M.  Seki.  1979. 1042  IN  VIVO  FATE  OF  CULTURED  MAST  CELLS 
Distribution  of mast-cell precursors in  hematopoietic and lymphopoietic tissues of 
mice.J. Exp. Med.  150:482. 
33.  Crowle, P. K., and N. D. Reed. 1984. Bone marrow origin of mucosal mast cells. Int. 
Arch. Allergy Appl. Immunol.  73:242. 
34.  Chi, E. Y., and D. Lagunoff. 1975. Abnormal mast cell granules in the beige (Chediak- 
Higashi syndrome) mouse. J. Histochem.  Cytochem. 23:117. 
35.  Kitamura, Y., M. Shimada, K. Hatanaka, and Y. Miyano. 1977. Development of mast 
cells from grafted bone marrow cells in irradiated mice. Nature (Lond.).  268:442. 
36.  Kitamura,  Y.,  M.  Yokoyama,  H.  Matsuda,  and  M.  Shimada.  1980.  Coincidental 
development of forestomach papilloma and prepyloric ulcer in nontreated  mutant 
mice of W/W  ~ and Sl/Sl d genotype. Cancer Res.  40:3392. 
37.  Tsuyama, K., T. Sonoda, Y. Kitamura, R. Inoue, T. Ochi, and K. Ono. 1982. Survival 
of host mast cells after establishment of hemopoietic chimeras by graft-versus-host 
reaction in nonirradiated F~ hybrid mice. Transplantation (Baltimore).  34:172. 
38.  Kitamura, Y.,  T.  Kawata,  O.  Suda,  and K.  Ezumi.  1970.  Changed differentiation 
pattern of colony-forming cells in  F1  hybrid mice suffering from graft-versus-host 
disease. Transplantation (Baltimore).  10:455. 
39.  Nakahata, T., S. S. Spicer, J. R. Cantey, and M. Ogawa. 1982. Clonal assay of mouse 
mast cell colonies in methylcellulose culture. Blood.  60:352. 
40.  Sonoda, T., Y. Kanayama, H. Hara, C. Hayashi, M. Tadokoro, T. Yonezawa, and Y. 
Kitamura. 1984. Proliferation of peritoneal mast cells in the skin of W]W  v mice that 
genetically lack mast cells. J. Exp. Med.  160:138. 
41.  Sonoda, T., T. Ohno, and Y. Kitamura. 1982. Concentration of mast-cell precursors 
in bone marrow, spleen, and blood of mice determined by limiting dilution analysis. 
J. Cell. Physiol.  112:136. 
42.  Mayrhofer, G.  1980.  Fixation and staining of granules in  mucosal mast cells and 
intraepithelial lymphocytes in the rat jejunum, with special reference to the relation- 
ship between the acid glycosaminoglycans in the two cell types. Histochem. J.  12:513. 
43.  Finney,  D.J.  1952.  Statistical  Method  in  Biological Assay. Charles Griffin & Co., 
Buckinghamshire, England. 570-585. 
44.  Porter, E. H., and R. J. Berry.  1963.  The efficient design of transplantable tumor 
assays. Br. J. Cancer.  17:583. 
45.  Breivik, H. 1971. Haematopoietic stem cell content of murine bone marrow, spleen, 
and blood. Limiting dilution analysis of diffusion chamber cultures. J.  Cell. Physiol. 
78:73. 
46.  Till, J.  E.,  and  E.  A.  McCulloch.  1961.  A  direct  measurement of the  radiation 
sensitivity of normal mouse bone marrow cells. Radiat. Res.  14:213. 
47.  Kitamura, Y.,  M.  Yokoyama, H. Matsuda,  T.  Ohno, and K. J.  Mori.  1981.  Spleen 
colony-forming cell  as  common precursor  for  tissue  mast cells and  granulocytes. 
Nature (Lond.). 291:159. 
48.  Enerb~ick,  L.  1974.  Berberine sulfate binding to mast cell polyanions: a cytofluoro- 
metric method for the quantitation of heparin. Histochemistry.  42:301. 
49.  Dimlich,  R.  V.  W.,  H. A.  Meineke,  F.  D.  Reiily, and  R. S.  McCuskey.  1980.  The 
fluorescent staining of heparin  in  mast cells using Berberine sulfate: compatibility 
with paraformaldehyde or 0-phthalaldehyde induced-fluorescence and metachroma- 
sia. Stain Technol.  55:217. 
50.  Yamada, K.  1974.  The effect of digestion with chondroitinases upon certain histo- 
chemical  reactions  of  mucosaccharide-containing  tissues.  J.  Histochem.  Cytochem. 
22:266. 
51.  Yamatodani,  A.,  K.  Maeyama, T.  Watanabe,  H.  Wade,  and  Y.  Kitamura.  1982. NAKANO  ET  AL.  1043 
Tissue  distribution  of histamine  in  a  mutant  mouse  deficient  in  mast cells:  clear 
evidence for the presence of non-mast-cell histamine. Biochem.  Pharmacol. 31:315. 
52.  Hasthorpe, S.  1980.  A  hemopoietic cell line dependent  upon a factor in pokeweed 
mitogen-stimulated spleen cell conditioning medium. J. Cell. Physiol.  105:379. 
53.  Dvorak,  A.  M.,  G.  Nabel,  K.  Pyne,  H.  Cantor,  H.  F.  Dvorak,  S. J.  Galli.  1982. 
Ultrastructural identification of the mouse basophil. Blood. 59:1279. 
54.  Katz, H. R., P. A. LeBlanc, and S. W. Russel.  1983. Two classes of mouse mast cells 
delineated by monoclonal antibodies. Proc. Natl. Acad. Sci. USA.  80:5916. 
55.  Bland, C. E.,  H. Ginsburg, J.  E.  Silbert, and D. D. Metcalfe.  1982.  Mouse heparin 
proteoglycan.  Synthesis  by mast ceil-fibroblast monolayers during  lymphocyte-de- 
pendent mast cell proliferation.J. Biol.  Chem.  257:8661. 
56.  Wong, G. H. W., I. Clark-LewisJ. L. McKimm-Breschkin, andJ. W. Schrader.  1982. 
Interferon-~,-like molecule induces  Ia antigens  on cultured  mast cell  progenitors. 
Proc. Natl. Acad. Sci. USA. 79:6989. 
57.  Galli, S.J. Mast cell heterogeneity: can variation in mast cell phenotype be explained 
without postulating distinct  cell lineages? In  Mast Cell  Differentiation and Hetero- 
geneity. A. D. Betus, J. A. Denberg, and J. Bienenstock, editors.  Raven Press, New 
York. In press. 